Annual Total Liabilities
$58.37 M
-$5.20 M-8.18%
December 31, 2023
Summary
- As of February 25, 2025, ANIK annual total liabilities is $58.37 million, with the most recent change of -$5.20 million (-8.18%) on December 31, 2023.
- During the last 3 years, ANIK annual total liabilities has fallen by -$34.84 million (-37.38%).
- ANIK annual total liabilities is now -37.38% below its all-time high of $93.20 million, reached on December 31, 2020.
Performance
ANIK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$51.54 M
-$776.00 K-1.48%
September 30, 2024
Summary
- As of February 25, 2025, ANIK quarterly total liabilities is $51.54 million, with the most recent change of -$776.00 thousand (-1.48%) on September 30, 2024.
- Over the past year, ANIK quarterly total liabilities has stayed the same.
- ANIK quarterly total liabilities is now -66.11% below its all-time high of $152.08 million, reached on June 30, 2020.
Performance
ANIK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ANIK Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.2% | 0.0% |
| 3 y3 years | -37.4% | -18.0% |
| 5 y5 years | +279.5% | +36.0% |
ANIK Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.2% | at low | -24.2% | at low |
| 5 y | 5-year | -37.4% | +37.9% | -66.1% | +21.8% |
| alltime | all time | -37.4% | +3333.3% | -66.1% | +3121.3% |
Anika Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $51.54 M(-1.5%) |
| Jun 2024 | - | $52.32 M(-5.2%) |
| Mar 2024 | - | $55.21 M(-5.4%) |
| Dec 2023 | $58.37 M(-8.2%) | $58.37 M(+1.2%) |
| Sep 2023 | - | $57.67 M(+5.1%) |
| Jun 2023 | - | $54.87 M(-10.8%) |
| Mar 2023 | - | $61.49 M(-3.3%) |
| Dec 2022 | $63.56 M(+5.2%) | $63.56 M(+1.2%) |
| Sep 2022 | - | $62.81 M(-7.6%) |
| Jun 2022 | - | $67.97 M(+20.4%) |
| Mar 2022 | - | $56.45 M(-6.6%) |
| Dec 2021 | $60.45 M(-35.1%) | $60.45 M(-3.8%) |
| Sep 2021 | - | $62.87 M(-17.6%) |
| Jun 2021 | - | $76.33 M(-10.8%) |
| Mar 2021 | - | $85.60 M(-8.2%) |
| Dec 2020 | $93.20 M(+120.2%) | $93.20 M(-29.3%) |
| Sep 2020 | - | $131.89 M(-13.3%) |
| Jun 2020 | - | $152.08 M(+44.5%) |
| Mar 2020 | - | $105.22 M(+148.6%) |
| Dec 2019 | $42.33 M(+175.2%) | $42.33 M(+11.7%) |
| Sep 2019 | - | $37.90 M(+4.1%) |
| Jun 2019 | - | $36.42 M(-3.1%) |
| Mar 2019 | - | $37.59 M(+144.4%) |
| Dec 2018 | $15.38 M(-19.6%) | $15.38 M(+9.9%) |
| Sep 2018 | - | $14.00 M(-25.6%) |
| Jun 2018 | - | $18.81 M(-8.6%) |
| Mar 2018 | - | $20.57 M(+7.5%) |
| Dec 2017 | $19.13 M(+9.5%) | $19.13 M(-3.6%) |
| Sep 2017 | - | $19.84 M(-4.9%) |
| Jun 2017 | - | $20.87 M(+20.3%) |
| Mar 2017 | - | $17.34 M(-0.8%) |
| Dec 2016 | $17.47 M(-29.8%) | $17.47 M(+5.8%) |
| Sep 2016 | - | $16.52 M(-9.8%) |
| Jun 2016 | - | $18.32 M(-4.0%) |
| Mar 2016 | - | $19.09 M(-23.3%) |
| Dec 2015 | $24.90 M(+69.3%) | $24.90 M(+7.8%) |
| Sep 2015 | - | $23.10 M(+32.4%) |
| Jun 2015 | - | $17.44 M(+9.9%) |
| Mar 2015 | - | $15.87 M(+7.9%) |
| Dec 2014 | $14.71 M(-27.9%) | $14.71 M(-6.9%) |
| Sep 2014 | - | $15.79 M(-5.4%) |
| Jun 2014 | - | $16.70 M(-4.5%) |
| Mar 2014 | - | $17.49 M(-14.3%) |
| Dec 2013 | $20.41 M(-38.4%) | $20.41 M(-28.8%) |
| Sep 2013 | - | $28.68 M(-1.0%) |
| Jun 2013 | - | $28.96 M(+1.5%) |
| Mar 2013 | - | $28.53 M(-13.9%) |
| Dec 2012 | $33.14 M(-13.0%) | $33.14 M(+5.6%) |
| Sep 2012 | - | $31.40 M(-11.9%) |
| Jun 2012 | - | $35.63 M(+1.9%) |
| Mar 2012 | - | $34.97 M(-8.2%) |
| Dec 2011 | $38.08 M(-12.9%) | $38.08 M(+3.1%) |
| Sep 2011 | - | $36.93 M(-8.3%) |
| Jun 2011 | - | $40.26 M(-2.2%) |
| Mar 2011 | - | $41.15 M(-5.9%) |
| Dec 2010 | $43.75 M(-7.5%) | $43.75 M(-3.8%) |
| Sep 2010 | - | $45.48 M(+2.7%) |
| Jun 2010 | - | $44.29 M(-3.6%) |
| Mar 2010 | - | $45.96 M(-2.8%) |
| Dec 2009 | $47.29 M(+34.9%) | $47.29 M(+47.1%) |
| Sep 2009 | - | $32.14 M(-3.8%) |
| Jun 2009 | - | $33.42 M(-1.8%) |
| Mar 2009 | - | $34.04 M(-2.9%) |
| Dec 2008 | $35.06 M | $35.06 M(+20.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2008 | - | $29.02 M(-4.9%) |
| Jun 2008 | - | $30.51 M(+17.0%) |
| Mar 2008 | - | $26.09 M(+6.3%) |
| Dec 2007 | $24.54 M(+8.4%) | $24.54 M(-14.2%) |
| Sep 2007 | - | $28.61 M(+13.0%) |
| Jun 2007 | - | $25.32 M(+15.7%) |
| Mar 2007 | - | $21.88 M(-3.3%) |
| Dec 2006 | $22.63 M(-8.5%) | $22.63 M(-7.9%) |
| Sep 2006 | - | $24.57 M(-0.1%) |
| Jun 2006 | - | $24.60 M(+7.0%) |
| Mar 2006 | - | $22.98 M(-7.1%) |
| Dec 2005 | $24.73 M(-15.2%) | $24.73 M(-4.0%) |
| Sep 2005 | - | $25.76 M(+2.2%) |
| Jun 2005 | - | $25.20 M(-8.8%) |
| Mar 2005 | - | $27.64 M(-5.3%) |
| Dec 2004 | $29.18 M(+650.2%) | $29.18 M(+11.4%) |
| Sep 2004 | - | $26.18 M(+9.8%) |
| Jun 2004 | - | $23.84 M(-11.4%) |
| Mar 2004 | - | $26.92 M(+592.1%) |
| Dec 2003 | $3.89 M(+28.6%) | $3.89 M(+49.4%) |
| Sep 2003 | - | $2.60 M(+21.9%) |
| Jun 2003 | - | $2.13 M(-17.8%) |
| Mar 2003 | - | $2.60 M(-14.1%) |
| Dec 2002 | $3.02 M(+7.5%) | $3.02 M(-14.2%) |
| Sep 2002 | - | $3.52 M(+14.6%) |
| Jun 2002 | - | $3.07 M(+9.6%) |
| Mar 2002 | - | $2.80 M(-0.3%) |
| Dec 2001 | $2.81 M(+24.1%) | $2.81 M(-14.0%) |
| Sep 2001 | - | $3.27 M(-13.3%) |
| Jun 2001 | - | $3.77 M(+59.4%) |
| Mar 2001 | - | $2.36 M(+4.3%) |
| Dec 2000 | $2.27 M(-66.7%) | $2.27 M(-64.1%) |
| Sep 2000 | - | $6.32 M(-13.6%) |
| Jun 2000 | - | $7.31 M(-0.3%) |
| Mar 2000 | - | $7.33 M(+7.7%) |
| Dec 1999 | $6.81 M(+172.4%) | $6.81 M(+209.6%) |
| Sep 1999 | - | $2.20 M(-8.3%) |
| Jun 1999 | - | $2.40 M(-11.1%) |
| Mar 1999 | - | $2.70 M(+8.0%) |
| Dec 1998 | $2.50 M(0.0%) | $2.50 M(+25.0%) |
| Sep 1998 | - | $2.00 M(-4.8%) |
| Jun 1998 | - | $2.10 M(-8.7%) |
| Mar 1998 | - | $2.30 M(-8.0%) |
| Dec 1997 | $2.50 M(+31.6%) | $2.50 M(+13.6%) |
| Sep 1997 | - | $2.20 M(+10.0%) |
| Jun 1997 | - | $2.00 M(+25.0%) |
| Mar 1997 | - | $1.60 M(0.0%) |
| Dec 1996 | $1.90 M(+11.8%) | - |
| Nov 1996 | - | $1.60 M(-5.9%) |
| Aug 1996 | - | $1.70 M(0.0%) |
| Aug 1996 | $1.70 M(-22.7%) | - |
| May 1996 | - | $1.70 M(-32.0%) |
| Feb 1996 | - | $2.50 M(+8.7%) |
| Nov 1995 | - | $2.30 M(+4.5%) |
| Aug 1995 | $2.20 M(-4.3%) | $2.20 M(-12.0%) |
| May 1995 | - | $2.50 M(+25.0%) |
| Feb 1995 | - | $2.00 M(-4.8%) |
| Nov 1994 | - | $2.10 M(-8.7%) |
| Aug 1994 | $2.30 M(-20.7%) | $2.30 M(-4.2%) |
| May 1994 | - | $2.40 M(+9.1%) |
| Feb 1994 | - | $2.20 M(-18.5%) |
| Nov 1993 | - | $2.70 M(-6.9%) |
| Aug 1993 | $2.90 M | $2.90 M(+31.8%) |
| May 1993 | - | $2.20 M |
FAQ
- What is Anika Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Anika Therapeutics?
- What is Anika Therapeutics annual total liabilities year-on-year change?
- What is Anika Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Anika Therapeutics?
- What is Anika Therapeutics quarterly total liabilities year-on-year change?
What is Anika Therapeutics annual total liabilities?
The current annual total liabilities of ANIK is $58.37 M
What is the all time high annual total liabilities for Anika Therapeutics?
Anika Therapeutics all-time high annual total liabilities is $93.20 M
What is Anika Therapeutics annual total liabilities year-on-year change?
Over the past year, ANIK annual total liabilities has changed by -$5.20 M (-8.18%)
What is Anika Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ANIK is $51.54 M
What is the all time high quarterly total liabilities for Anika Therapeutics?
Anika Therapeutics all-time high quarterly total liabilities is $152.08 M
What is Anika Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ANIK quarterly total liabilities has changed by $0.00 (0.00%)